Home » Stocks » Helix Acquisition

Helix Acquisition Corp. (HLXA)

Helix Acquisition will go public soon. The estimated IPO date is October 20, 2020.

Stock Price: $10.00

Confirmed IPO price

Stock Price Chart

Key Info

Market Cap	129.00M
Revenue (ttm)	n/a
Net Income (ttm)	-5,000
Shares Out	12.90M
EPS (ttm)	0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Dividend Yield	n/a

Stock Quote

Trading Day	n/a
Last Price	n/a
Previous Close	n/a
Change ($)	n/a
Change (%)	n/a
Day's Open	n/a
Day's Range	n/a
Day's Volume	n/a
52-Week Range	n/a

More Stats

Market Cap	129.00M
Enterprise Value	n/a
Earnings Date (est)	n/a
Ex-Dividend Date	n/a
Shares Outstanding	12.90M
Float	n/a
EPS (basic)	n/a
EPS (diluted)	0.00
FCF / Share	n/a

Dividend	n/a
Dividend Yield	n/a
Earnings Yield	0.00%
FCF Yield	n/a
Payout Ratio	n/a
Shares Short	n/a
Short Ratio	n/a
Short % of Float	n/a
Beta	n/a

PE Ratio	n/a
Forward PE	n/a
P/FCF Ratio	n/a
PS Ratio	n/a
PB Ratio	n/a
Revenue	n/a
Operating Income	n/a
Net Income	-5,000
Free Cash Flow	n/a

Net Cash	n/a
Net Cash / Share	n/a
Gross Margin	n/a
Operating Margin	n/a
Profit Margin	n/a
FCF Margin	n/a
ROA	n/a
ROE	n/a
ROIC	n/a

Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy	0
Overweight	0
Hold	0
Underweight	0
Sell	0

What these ratings mean

Analyst Consensus: n/a

Price Target

$n/a*

*No analysts have provided price targets for this stock.

Financial Performance

Financial Overview

No financial data available for this stock yet.

Company Profile

Company Details

Full Name	Helix Acquisition Corp.
Country	United States
CEO	Bihua Chen

Stock Information

Ticker Symbol	HLXA
Stock Exchange	NASDAQ
Industry	Blank Checks / SPAC
Unique Identifier	NASDAQ: HLXA
IPO Date	October 20, 2020

Description

Helix Acquisition Corp. is a newly incorporated blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While we may pursue a business combination target in any business or industry, we intend to focus on healthcare or healthcare related industries, which can benefit from the expertise and capabilities of our management team in order to create long-term shareholder value. Our management team is led by Bihua Chen, our Chief Executive Officer and Chairman of our board of directors, and Jay Scollins, our Chief Financial Officer, each of whom has significant experience building, operating and investing in the life sciences and medical technology sectors globally.